ORMP

Oramed Pharmaceuticals Inc.

Sector: healthcareBiotechnologyNASDAQMarket Cap: $128.3M

Oramed Pharmaceuticals is a clinical-stage biotech developing oral insulin and GLP-1 therapies with minimal political/regulatory footprint and no active lobbying presence.

Govt Dependence

5/100

Regulatory Density

35/100

Lobbying Intensity

0/100

Political Signal

LOW

BusinessWhat ORMP does

Oramed develops proprietary oral drug-delivery technologies targeting diabetes and obesity, primarily oral insulin (ORMD-0801) and GLP-1 candidates. The company is pre-commercial with no approved products and minimal revenue, relying on R&D funding and capital markets.

Lifetime Government AwardsORMP federal contracts

ORMP doesn't hold direct federal contracts.

Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.

Smart Money · 13F HoldingsHedge funds holding ORMP

$5.8M

Total ORMP held by tracked 13F funds

Funds with ORMP positions

+22

Funds opened this quarter

Renaissance Technologies $599K opened 2024-09-30

Renaissance Technologies $593K opened 2024-06-30

Citadel Advisors $529K opened 2025-12-31

Renaissance Technologies $420K opened 2025-12-31

Renaissance Technologies $393K opened 2025-09-30

Two Sigma Investments $393K opened 2024-03-31

Two Sigma Investments $386K opened 2024-06-30

Renaissance Technologies $367K opened 2024-12-31

14 more 13F positions tracked · quarterly delta charts available in member dashboard

Politicians Trading ORMPMembers of Congress with recent ORMP positions

1 politicians traded ORMP across 2 disclosed transactions totaling $65K (last 730 days). Greed score = composite of trade frequency, volume & recency across the politician's entire history (not just ORMP). 0-30 LOW · 30-60 MID · 60+ HIGH.

Brad Knott R-North Carolina · house 2 sells $65K 2025-01-10 LOW · 0

Congressional TradesWho in Congress is trading ORMP

2025-01-10 Brad Knott R-North Carolina · house Sale $15,001 - $50,000 46d late

2025-01-10 Brad Knott R-North Carolina · house sale $15,001 - $50,000 46d late

2022-01-14 Andrew R. Garbarino R-New York · house sale $1,001 - $15,000

2022-01-14 Andrew R. Garbarino R-New York · house Sale $1,001 - $15,000

2021-10-01 Andrew R. Garbarino R-New York · house Sale $1,001 - $15,000

2021-10-01 Andrew R. Garbarino R-New York · house sale $1,001 - $15,000

2021-04-23 Andrew R. Garbarino R-New York · house Purchase $1,001 - $15,000

2021-04-23 Andrew R. Garbarino R-New York · house purchase $1,001 - $15,000

8+ trades on file · most recent 2025-02-25

Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock

No Form 4 activity recorded in the last 180 days.

Bills to WatchLegislation flagged by our analysis

FDA drug approval pathwaysMedicare drug pricing reform

Political ProfileWhere ORMP sits in Washington

As a pre-commercial biotech with no lobbying activity and minimal political engagement, stock movement is driven by clinical trial results and capital markets, not legislative/regulatory events. Political exposure only materializes post-approval.

Regulatory ExposureThreats & opportunities

Regulatory threats

FDA clinical trial delays
drug pricing pressure post-approval

Regulatory opportunities

FDA breakthrough therapy designation
accelerated approval pathways for diabetes/obesity

Member intelligence layer

Live signals + predictions for ORMP — for Founders

The free page above gives you the public record. Members see the real-time intelligence layer on top of it:

Live 7-layer signal scores when Congress trades ORMP
Bill Pass Index v2 odds for every bill on the watch list
Iron Triangle alerts (committee × donor × trade)
SEC Form 4 cluster detection (CEO + CFO + director buys)
Whale-Opportunity expected-value ranking
Custom watchlist alerts via email + Discord

Become a Founder · $24.50/mo Locked rate forever · cancel anytime

Frequently AskedAbout ORMP & political exposure

Does Oramed Pharmaceuticals Inc. (ORMP) hold federal contracts?

No direct prime contracts reported in USASpending.gov for Oramed Pharmaceuticals Inc.. Companies in the semiconductor and AI hardware sectors often sell to the federal government via prime contractors and cloud resellers (Microsoft Azure, AWS, Lockheed Martin systems integration) rather than as direct primes.

Has Congress traded ORMP stock?

8 congressional trades by 2 unique members of Congress, most recently on 2025-01-10. See the Congressional Trading panel for politician-by-politician breakdown.

What is ORMP political risk profile?

Government dependence: 5/100. Lobbying intensity: 0/100. Political signal: low.

How does GovGreed track ORMP political activity?

GovGreed integrates STOCK Act congressional trade disclosures, FEC contributions, OGE executive-branch disclosures, USASpending federal contracts, Senate LDA lobbying filings, and SEC Form 4 corporate insider trades into a single queryable graph. ORMP data is updated daily from these official federal sources.